FDA Investigator: Lillian S. Wu

- Lillian S. Wu first started conducting FDA inspections in 2022, with the last inspection in 2024. Over that time, Lillian S. Wu has conducted 18 inspections at 16 companies across 18 sites.

Get Lillian Wu's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Hunan Yuxin Pharmaceutical Co., Ltd, Shaoyang | 2024

Out-of-stock
Lillian S. Wu
Human Drugs Form 483

FDA 483 Zhejiang Huayang Pharmaceutical Co., Ltd., Linhai | 2024

Out-of-stock
Lillian S. Wu
Human Drugs Form 483

FDA 483 Medsource Pharmaceuticals, Rancho Santa Margarita | 2023

Out-of-stock
Lillian S. Wu
Human Drugs Form 483

FDA 483 THE HAIN CELESTIAL, Bell | 2023

Out-of-stock
Lillian S. Wu
Human Drugs Form 483

FDA 483 OrBion Pharmaceuticals Private Limited, Sriperumbudur | 2023

Out-of-stock
Lillian S. Wu
Human Drugs Form 483

FDA 483 Cronus Pharma Specialities India Pvt Ltd, Hyderabad | 2023

Out-of-stock
Lillian S. Wu
Animal Drugs & Feeds Form 483

FDA 483 Packaging On Demand, Inc., San Clemente | 2023

Out-of-stock
Lillian S. Wu
Human Drugs Form 483

FDA 483 AIRGAS USA, LLC., Billerica | 2022

Out-of-stock
Lillian S. Wu
Human Drug Form 483

FDA 483 AIRGAS USA, LLC., Tucson | 2022

Out-of-stock
Lillian S. Wu
Human Drug Form 483

FDA 483 Bryant Ranch Prepack, Inc., Burbank | 2022

Out-of-stock
Lillian S. Wu
Human Drug Form 483